Register of Patients With haEmophilia A tReated With Afstyla®

German Pediatric Hemophilia Research Database

NCT02912143 ·Status: RECRUITING

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

NCT03655340 ·Status: COMPLETED

Study Evaluating ReFacto AF in Severe Hemophilia A

NCT00037544 ·Status: COMPLETED ·Phase: PHASE3

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301 ·Status: COMPLETED

UK - EHL Outcomes Registry

NCT02938156 ·Status: UNKNOWN

A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment

NCT02476942 ·Status: COMPLETED

Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia

NCT07099313 ·Status: RECRUITING

Combining Registry Data in Haemophilia: TARGET H

NCT03264014 ·Status: COMPLETED

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

NCT00950170 ·Status: COMPLETED ·Phase: PHASE4

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881 ·Status: COMPLETED

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

NCT00243659 ·Status: COMPLETED ·Phase: PHASE3

Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.

NCT03054662 ·Status: COMPLETED ·Phase: NA

Epidemiology and Immunology of Hemophilia A Inhibitors

NCT00005518 ·Status: COMPLETED

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

NCT05911763 ·Status: ACTIVE_NOT_RECRUITING

Long-term Anticoagulation in a Patient With Severe Hemophilia A

NCT07314983 ·Status: RECRUITING

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

NCT02078427 ·Status: COMPLETED

Study Evaluating Inhibitor Specificity in Hemophilia A

NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4

An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

NCT03901755 ·Status: COMPLETED

Data Registry in Chinese Hemophilia A and B Patients

NCT07101224 ·Status: COMPLETED

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

NCT00703911 ·Status: COMPLETED

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814 ·Status: RECRUITING ·Phase: PHASE3

Quality of Life Study of Helixate NexGen

NCT01053715 ·Status: COMPLETED

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

NCT02319070 ·Status: COMPLETED

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

NCT04165135 ·Status: COMPLETED